CRISPR-enhanced adipocyte browning to improve glucose tolerance in obesity and diabetes

CRISPR 增强脂肪细胞褐变以改善肥胖和糖尿病的葡萄糖耐量

基本信息

项目摘要

The long term goal of this project is to advance a CRISPR-based technology that genetically modifies human white adipocytes to a “brown-like”, thermogenic phenotype with greatly enhanced ability to promote metabolic health when implanted into obese, diabetic mice. Gene targeting is accomplished in this project without viral or expression vectors, but rather by delivering purified, endotoxin-free Cas9 protein and sgRNA complexes to adipocyte progenitors with nearly 100 percent efficiency. The central hypothesis we will test is that simultaneous CRISPR-based disruption of two distinct “browning suppression” pathways will synergize and convert abundant human white adipocytes to large numbers of rare, fully “brown- like”, therapeutic adipocytes. An attractive transcriptional suppressor target is NRIP1/RIP140, which when deleted by CRISPR in adipocytes causes 100-fold increases in expression of UCP1 and other “BAT” genes. We recently found Nrip1KO mouse or human adipocytes improve metabolic health when implanted in obese mice. An attractive suppressor target in a second thermogenic pathway (cAMP signaling) is the inhibitory RIIb subunit (gene Prkar2) of protein kinase A, which when deleted also upregulates UCP1. Remarkably, we found agonist stimulation of cAMP in Nrip1KO adipocytes upregulates UCP1 and beneficial factors in synergistic mode, approaching a full BAT phenotype. Specific Aim 1 will test the central hypothesis in vitro, leveraging lessons we learned during development of this CRISPR method under pilot Department of Defense funding. First, not all sgRNAs that cause indels in the target gene Nrip1 actually delete the protein. Thus, screening 10 to 20 Prkar2 sgRNAs will be performed in mouse and human adipocytes to define the most efficient at RIIb protein deletion and upregulation of UCP1, with least off-target effects. Second, conditions in which multiple sgRNAs function at near 100 percent efficiency will be used, allowing analysis of adipocytes with single Nrip1KO or Prkar2KO vs adipocytes with double Nrip1/prkar2KO. Efficacy of “brown-like” phenotype induction will be analyzed by cAMP determinations, Western blot and RT-PCR for thermogenic and beneficial secreted proteins, RNAseq signatures and glycolytic and oxygen consumption rates. We will thus determine whether deletion of RIIb plus NRIP1 proteins in mouse and human adipocytes is synergistic, converting white adipocytes to a near BAT phenotype. In Specific Aim 2, these CRISPR-engineered mouse and human adipocytes will be implanted in HFD fed wild type mice or HFD fed immune-compromised NSG mice, respectively. These studies will determine whether double Nrip1KO/Prkar2KO adipocytes are most effective in forming brown-like, implanted adipose depots, including extent of innervation and vascularization (light sheet microscopy). The implanted mice will be evaluated for glucose tolerance and energy expenditure (hyperinsulinemic clamp and metabolic cages). This project will thus define whether CRISPR-engineered mouse and human adipocytes doubly depleted of RIIb plus NRIP1 proteins have greater therapeutic potential than single KO or unmodified adipocytes.
该项目的长期目标是推进基于CRISPR的技术,该技术将人类白色脂肪细胞遗传修饰为“棕色样”产热表型,当植入肥胖糖尿病小鼠时,其促进代谢健康的能力大大增强。在这个项目中,基因靶向是在没有病毒或表达载体的情况下完成的,而是通过将纯化的、无内毒素的Cas9蛋白和sgRNA复合物以接近100%的效率递送到脂肪祖细胞。我们将检验的中心假设是,两种不同的“布朗宁抑制”途径的同时基于CRISPR的破坏将协同作用并将丰富的人白色脂肪细胞转化为大量罕见的完全“棕色样”治疗性脂肪细胞。一个有吸引力的转录抑制靶点是NRIP 1/RIP 140,当在脂肪细胞中被CRISPR删除时,它会导致UCP 1和其他“BAT”基因的表达增加100倍。我们最近发现Nrip 1 KO小鼠或人类脂肪细胞在植入肥胖小鼠时可改善代谢健康。在第二产热途径(cAMP信号传导)中的有吸引力的抑制剂靶标是蛋白激酶A的抑制性RIIb亚基(基因Prkar 2),其在缺失时也上调UCP 1。值得注意的是,我们发现Nrip 1 KO脂肪细胞中cAMP的激动剂刺激以协同模式上调UCP 1和有益因子,接近完整的BAT表型。具体目标1将在体外测试中心假设,利用我们在国防部试点资金下开发这种CRISPR方法期间学到的经验教训。首先,并非所有在靶基因Nrip 1中引起indel的sgRNA实际上都会删除蛋白质。因此,将在小鼠和人脂肪细胞中筛选10至20种Prkar 2 sgRNA,以确定最有效的RIIb蛋白缺失和UCP 1上调,且脱靶效应最小。其次,将使用多个sgRNA以接近100%的效率发挥作用的条件,允许分析具有单个Nrip 1 KO或Prkar 2 KO的脂肪细胞与具有双Nrip 1/prkar 2 KO的脂肪细胞。将通过cAMP测定、蛋白质印迹和RT-PCR分析产热和有益分泌蛋白、RNAseq签名以及糖酵解和耗氧速率来分析“棕色样”表型诱导的功效。因此,我们将确定小鼠和人脂肪细胞中RIIb加NRIP 1蛋白的缺失是否是协同的,将白色脂肪细胞转化为接近BAT的表型。在具体目标2中,这些CRISPR工程化的小鼠和人脂肪细胞将分别植入HFD喂养的野生型小鼠或HFD喂养的免疫受损的NSG小鼠中。这些研究将确定双Nrip 1 KO/Prkar 2KO脂肪细胞是否最有效地形成棕色样植入脂肪库,包括神经支配和血管化的程度(光片显微镜)。将评价植入小鼠的葡萄糖耐量和能量消耗(高胰岛素钳夹和代谢笼)。因此,该项目将确定CRISPR工程化的小鼠和人类脂肪细胞是否双重耗尽RIIb加NRIP 1蛋白,比单一KO或未修饰的脂肪细胞具有更大的治疗潜力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL P CZECH其他文献

MICHAEL P CZECH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL P CZECH', 18)}}的其他基金

CRISPR-enhanced adipocyte browning to improve glucose tolerance in obesity and diabetes
CRISPR 增强脂肪细胞褐变以改善肥胖和糖尿病的葡萄糖耐量
  • 批准号:
    10649531
  • 财政年份:
    2021
  • 资助金额:
    $ 64.99万
  • 项目类别:
CRISPR-enhanced adipocyte browning to improve glucose tolerance in obesity and diabetes
CRISPR 增强脂肪细胞褐变以改善肥胖和糖尿病的葡萄糖耐量
  • 批准号:
    10490350
  • 财政年份:
    2021
  • 资助金额:
    $ 64.99万
  • 项目类别:
Adipocyte to neuron signaling in thermogenic programming of white adipose tissue
白色脂肪组织产热编程中的脂肪细胞至神经元信号传导
  • 批准号:
    10547782
  • 财政年份:
    2019
  • 资助金额:
    $ 64.99万
  • 项目类别:
Adipocyte to neuron signaling in thermogenic programming of white adipose tissue
白色脂肪组织产热编程中的脂肪细胞至神经元信号传导
  • 批准号:
    9889952
  • 财政年份:
    2019
  • 资助金额:
    $ 64.99万
  • 项目类别:
Adipocyte to neuron signaling in thermogenic programming of white adipose tissue
白色脂肪组织产热编程中的脂肪细胞至神经元信号传导
  • 批准号:
    10341100
  • 财政年份:
    2019
  • 资助金额:
    $ 64.99万
  • 项目类别:
Adipocyte to neuron signaling in thermogenic programming of white adipose tissue
白色脂肪组织产热编程中的脂肪细胞至神经元信号传导
  • 批准号:
    10087919
  • 财政年份:
    2019
  • 资助金额:
    $ 64.99万
  • 项目类别:
Insulin Signaling and Metabolic Regulation in Adipocytes
脂肪细胞中的胰岛素信号传导和代谢调节
  • 批准号:
    10194465
  • 财政年份:
    2017
  • 资助金额:
    $ 64.99万
  • 项目类别:
Paracrine Signaling by Kupffer Cells in Hepatic Insulin Resistance
肝胰岛素抵抗中库普弗细胞的旁分泌信号传导
  • 批准号:
    8888443
  • 财政年份:
    2015
  • 资助金额:
    $ 64.99万
  • 项目类别:
Paracrine Signaling by Kupffer Cells in Hepatic Insulin Resistance
肝胰岛素抵抗中库普弗细胞的旁分泌信号传导
  • 批准号:
    9029321
  • 财政年份:
    2015
  • 资助金额:
    $ 64.99万
  • 项目类别:
Mechanisms of insulin resistance related to nonalcoholic steatohepatitis
非酒精性脂肪性肝炎相关胰岛素抵抗机制
  • 批准号:
    10161771
  • 财政年份:
    2015
  • 资助金额:
    $ 64.99万
  • 项目类别:

相似海外基金

Deciphering the role of adipose tissue in common metabolic disease via adipose tissue proteomics
通过脂肪组织蛋白质组学解读脂肪组织在常见代谢疾病中的作用
  • 批准号:
    MR/Y013891/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.99万
  • 项目类别:
    Research Grant
ESTABLISHING THE ROLE OF ADIPOSE TISSUE INFLAMMATION IN THE REGULATION OF MUSCLE MASS IN OLDER PEOPLE
确定脂肪组织炎症在老年人肌肉质量调节中的作用
  • 批准号:
    BB/Y006542/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.99万
  • 项目类别:
    Research Grant
Canadian Alliance of Healthy Hearts and Minds: Dissecting the Pathways Linking Ectopic Adipose Tissue to Cognitive Dysfunction
加拿大健康心灵联盟:剖析异位脂肪组织与认知功能障碍之间的联系途径
  • 批准号:
    479570
  • 财政年份:
    2023
  • 资助金额:
    $ 64.99万
  • 项目类别:
    Operating Grants
Determinants of Longitudinal Progression of Adipose Tissue Inflammation in Individuals at High-Risk for Type 2 Diabetes: Novel Insights from Metabolomic Profiling
2 型糖尿病高危个体脂肪组织炎症纵向进展的决定因素:代谢组学分析的新见解
  • 批准号:
    488898
  • 财政年份:
    2023
  • 资助金额:
    $ 64.99万
  • 项目类别:
    Operating Grants
Activation of human brown adipose tissue using food ingredients that enhance the bioavailability of nitric oxide
使用增强一氧化氮生物利用度的食品成分激活人体棕色脂肪组织
  • 批准号:
    23H03323
  • 财政年份:
    2023
  • 资助金额:
    $ 64.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of new lung regeneration therapies by elucidating the lung regeneration mechanism of adipose tissue-derived stem cells
通过阐明脂肪组织干细胞的肺再生机制开发新的肺再生疗法
  • 批准号:
    23K08293
  • 财政年份:
    2023
  • 资助金额:
    $ 64.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A study on the role of brown adipose tissue in the development and maintenance of skeletal muscles
棕色脂肪组织在骨骼肌发育和维持中作用的研究
  • 批准号:
    23K19922
  • 财政年份:
    2023
  • 资助金额:
    $ 64.99万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Adipose Tissue T Cell Polarization and Metabolic Health in Persons Living with HIV
HIV 感染者的脂肪组织 T 细胞极化和代谢健康
  • 批准号:
    10619176
  • 财政年份:
    2023
  • 资助金额:
    $ 64.99万
  • 项目类别:
Estrogen Signaling in the Ventromedial Hypothalamus Modulates Adipose Tissue Metabolic Adaptation
下丘脑腹内侧区的雌激素信号调节脂肪组织代谢适应
  • 批准号:
    10604611
  • 财政年份:
    2023
  • 资助金额:
    $ 64.99万
  • 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
  • 批准号:
    10813753
  • 财政年份:
    2023
  • 资助金额:
    $ 64.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了